<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: The aim of the study was to evaluate <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> and <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> frequency (according to current criteria) in women with <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">recurrent miscarriages</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIAL AND METHODS: We examined 105 women diagnosed due to <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">recurrent miscarriages</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Patients were divided into 2 groups: with early <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">recurrent miscarriages</z:e> and with late <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">recurrent miscarriages</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The third group was the control group composed of 30 healthy women without poor obstetric history and having at least one child </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> women were screened for the presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo>: anticardiolipin antibodies, anti beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> antibodies and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: <z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> were found in 12.4% of women with recurrent pregnancy loss and in 13.3% of the controls </plain></SENT>
<SENT sid="6" pm="."><plain>Among 87 patients in group I with early <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">recurrent miscarriages</z:e> the most common antibodies were: anti-beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I (9.2%), anticardiolipin antibodies (4.6%) and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (1.1%) </plain></SENT>
<SENT sid="7" pm="."><plain>Anti beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> antibodies were the only antibodies found in 18 women in group II with recurrent late <z:e sem="disease" ids="C0000786" disease_type="Disease or Syndrome" abbrv="">miscarriages</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>There were 13.3% aPL-positive cases in the control group </plain></SENT>
<SENT sid="9" pm="."><plain>Among the studied population, there were only two patients (2.3%) fulfilling the criteria of APS </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: 1 </plain></SENT>
<SENT sid="11" pm="."><plain>The presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> in low titers in women with pregnancy loss is unequivocal with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>2 </plain></SENT>
<SENT sid="13" pm="."><plain>APL screening should be limited to a restricted group of women </plain></SENT>
</text></document>